Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs

Thread starter U.S. News
Start date Feb 11, 2026

U.S. News

Guest

Feb 11, 2026

Doustdar said Medicare coverage and the launch of Novo's new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs

Prefix: N/A

Forum: USA News

Start date: Feb 11, 2026

Last reply date: Feb 11, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Feb 11, 2026

Replies: 0

Views: 1

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search